Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population

Journal of the National Cancer Institute

Volumn 100, Issue 8, 2008, Pages 597-598

  Caan, Bette ^a   Habel, Laurel ^a   Quesenberry, Charles ^a   Kushi, Larry ^a   Herrinton, Lisa ^a  

^a DIVISION OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; BREAST CANCER; CANCER INCIDENCE; CANCER INVASION; CANCER REGISTRY; CANCER SCREENING; DRUG USE; FEMALE; HEALTH CARE UTILIZATION; HORMONAL THERAPY; HUMAN; LETTER; MAMMOGRAPHY; POPULATION RESEARCH; POSTMENOPAUSE; PRIORITY JOURNAL; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; CHEMISTRY; ESTROGEN THERAPY; INCIDENCE; MASS SCREENING; METHODOLOGY; NEOPLASM; NOTE; RADIOGRAPHY; REGISTER; UNITED STATES; UTILIZATION REVIEW; WOMEN'S HEALTH;

ESTROGEN RECEPTOR; TUMOR MARKER;

BREAST NEOPLASMS; CALIFORNIA; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; INCIDENCE; MAMMOGRAPHY; MASS SCREENING; NEOPLASMS, HORMONE-DEPENDENT; POSTMENOPAUSE; RECEPTORS, ESTROGEN; REGISTRIES; TUMOR MARKERS, BIOLOGICAL; WOMEN'S HEALTH;

EID: 43149106215     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djn079     Document Type: Letter

References (5)

1. Clarke CA, Glaser SL, Uratsu CS, Selby JV, Kushi LH, Herrinton LJ. Recent declines in hormone therapy utilization and breast cancer incidence: clinical and population-based evidence. J Clin Oncol. 2006;24(33):e49-e50.
2. Ravdin PM, Cronin KA, Howlader N, et al. The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med. 2007;356(16):1670-1674.
3. Glass AG, Lacey JV Jr, Carreon JD, Hoover RN. Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. J Natl Cancer Inst. 2007;99(15):1152-1161.
4. Kerlikowske K, Miglioretti DL, Buist DS, Walker R, Carney PA. Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. J Natl Cancer Inst. 2007;99(17):1335-1339.
5. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288(3):321-333.